|
Canada-0-MATTRESSES företaget Kataloger
|
Företag Nyheter:
- Is psychedelic use associated with cancer?: Interrogating a half . . .
While laboratory studies and case reports from the 1960s and 1970s generated concerns about psychedelics' carcinogenic potential, this analysis of recent epidemiological data does not support an association between psychedelic use and development of cancer in general or hematologic cancer
- Could psychedelic drugs relieve cancer pain? | Roswell Park . . .
“Psilocybin and other psychedelic drugs have some unique properties that seem to address other dimensions of suffering and pain,” notes Dr Alexander He says that despite the lingering ’60s reputation of psychedelic drugs, they do not appear to have strong addictive potential
- Exploring Psychedelic-Assisted Therapy in Oncology
One of psychedelic-assisted therapy’s most compelling implications is its ability to address the deep existential distress that often accompanies a cancer diagnosis—the questions of meaning, mortality, and legacy that conventional treatments frequently overlook
- Psychedelic substances - Cancer Science
Psychedelic substances hold significant potential for improving the quality of life for cancer patients While more research is needed to fully understand their benefits and risks, early findings are promising
- How Can Psychedelics Affect Patients With Cancer? | CURE
Psychedelics may have a positive effect on the mental health of patients with cancer, as one expert explained in an interview CURE spoke with Dr Michael Bogenschutz, director of the NYU Langone Center for Psychedelic Medicine in New York
- Psilocybin, peyote, mescaline, and lysergic acid diethylamide (LSD) use . . .
These findings, while limited by temporality of diagnosis and initiation of psychedelic use, underscore the need to investigate reasons and long-term impact of specific psychedelic use with more rigor among adults with a cancer history
- Large national survey suggests that the use of psychedelics is not . . .
In the 1960s, research surfaced linking psychedelic use to an increased risk of cancer But a new study published in the Journal of Psychopharmacology found no such link
- Psychedelic Drug Therapy May Address Mental Health Concerns in People . . .
“Our findings suggest that the mental health benefits of psilocybin therapy for cancer patients may reach far beyond what we have previously understood,” said study lead author Petros D Petridis, MD, a clinical assistant professor in the Department of Psychiatry at NYU Grossman School of Medicine
- Integrating Emotional Healing Through Psychedelics Into Everyday . . .
As interest in psychedelic-assisted therapy grows across oncology and palliative care settings, the use of psilocybin to address the emotional and existential distress experienced by patients with cancer is emerging as a powerful tool to help patients heal emotionally after healing physically
- Is psychedelic use associated with cancer?: Interrogating a half . . .
While laboratory studies and case reports from the 1960s and 1970s generated concerns about psychedelics’ carcinogenic potential, this analysis of recent epidemiological data does not support an association between psychedelic use and development of cancer in general or hematologic cancer
|
|